Why the study?
Pulmonary hypertension carries up to 40% 5-year mortality in COPD, but significant disease heterogeneity has limited the ability to identify effective treatments.
Does cluster analysis using quantitative CT and pulmonary function metrics identify distinct phenotypes with differential mortality in COPD patients with pulmonary artery enlargement?
Does cluster analysis using quantitative CT and pulmonary function metrics identify distinct phenotypes with differential mortality in COPD patients with pulmonary artery enlargement?
Quantitative CT imaging combined with clinical features identifies distinct subgroups of COPD patients with pulmonary artery enlargement who have significantly different mortality risks and disease phenotypes.
CT-based clustering may stratify mortality risk in COPD with PA enlargement; hypothesis-generating and requires prospective validation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Johnson et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: